Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Targeting the molecular web of Alzheimer’s disease: unveiling pathways for effective pharmacotherapy ; volume:60 ; number:1 ; day:11 ; month:1 ; year:2024 ; pages:1-24 ; date:12.2024
The Egyptian journal of neurology, psychiatry and neurosurgery ; 60, Heft 1 (11.1.2024), 1-24, 12.2024
- Urheber
-
Jadhav, Devika
Saraswat, Nikita
Vyawahare, Neeraj
Shirode, Devendra
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41983-023-00775-8
- URN
-
urn:nbn:de:101:1-2024032511474900600780
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jadhav, Devika
- Saraswat, Nikita
- Vyawahare, Neeraj
- Shirode, Devendra
- SpringerLink (Online service)
Ähnliche Objekte (12)
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
Unravelling the mechanotransduction pathways in Alzheimer’s disease
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
Unravelling the mechanotransduction pathways in Alzheimer’s disease
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group
Golgi-targeting viscosity probe for the diagnosis of Alzheimer’s disease
Targeting psychologic stress signaling pathways in Alzheimer’s disease
Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer’s Disease
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Alzheimer’s disease: targeting the glutamatergic system
Alzheimer’s disease: targeting the peripheral circulation
Unveiling disulfidptosis-related biomarkers and predicting drugs in Alzheimer’s disease
Unravelling the mechanotransduction pathways in Alzheimer’s disease
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
Therapeutic approaches targeting Apolipoprotein E function in Alzheimer’s disease
Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
A Framework for Developing Pharmacotherapy for Agitation in Alzheimer’s disease: Recommendations of the ISCTM Working Group